Page last updated: 2024-09-05

ramelteon and Airflow Obstruction, Chronic

ramelteon has been researched along with Airflow Obstruction, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kryger, M; Roth, T; Wang-Weigand, S; Zhang, J2

Trials

2 trial(s) available for ramelteon and Airflow Obstruction, Chronic

ArticleYear
The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.
    Sleep & breathing = Schlaf & Atmung, 2009, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Comorbidity; Cross-Over Studies; Double-Blind Method; Female; Humans; Indenes; Male; Oximetry; Polysomnography; Pulmonary Disease, Chronic Obstructive; Receptors, Melatonin; Severity of Illness Index; Sleep Apnea Syndromes; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Sleep Stages; Young Adult

2009
Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD.
    Sleep & breathing = Schlaf & Atmung, 2008, Volume: 12, Issue:3

    Topics: Aged; Cross-Over Studies; Double-Blind Method; Electroencephalography; Electrooculography; Female; Humans; Indenes; Male; Middle Aged; Polysomnography; Pulmonary Disease, Chronic Obstructive; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Respiration; Severity of Illness Index

2008